To amend title XVIII of the Social Security Act to allow individuals with Alzheimer's disease to buy in to the Medicare program.
Summary
HR10726, introduced by Rep. Davics on October 5, 2026, would amend the Social Security Act to allow individuals with Alzheimer's disease to buy into Medicare. The bill is in early stage with no cosponsors and has been referred to the Committees on Ways and Means and Energy and Commerce. No direct market impact is expected in the near term.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR10726 is a low-probability bill with no immediate market implications.
- 2.The bill has zero cosponsors and is in early committee stage, indicating low legislative momentum.
- 3.No ticker-level impact is identifiable; investors should not adjust positions based on this introduction.
Market Implications
No direct market implications at this stage. The bill's early stage and lack of cosponsors suggest low legislative priority. If the bill advances, Medicare Advantage insurers and Alzheimer's drug developers could see indirect effects, but that is not actionable now.
Full Analysis
On October 5, 2026, Rep. Sharice Davics (D-KS-3) introduced HR10726 in the 119th Congress. The bill proposes to amend Title XVIII of the Social Security Act to permit individuals diagnosed with Alzheimer's disease to purchase Medicare coverage. It was immediately referred to the Committee on Ways and Means and the Committee on Energy and Commerce for consideration of relevant provisions. The bill has zero cosponsors and no further legislative action has occurred.
The bill does not authorize or appropriate any specific funding. It is a eligibility-expansion measure that would allow a defined population to buy into the existing Medicare program. Any financial impact would depend on future premium-setting by the Centers for Medicare & Medicaid Services (CMS) and the resulting enrollment behavior. Since the bill is purely permissive (no mandate for individuals to enroll), the actual revenue or cost effects are speculative at this stage.
No related signals, procurement actions, or presidential actions were provided in the enrichment data. The financial data supplied pertains to the energy sector and is not relevant to this healthcare bill. Consequently, there is no convergence to report.
At this early legislative stage, no publicly traded company is directly and measurably impacted. If the bill were to advance, Medicare Advantage insurers (e.g., UnitedHealth Group $UNH, Humana $HUM) could face changes in their risk pools, and pharmaceutical companies with Alzheimer's therapies (e.g., Biogen $BIIB, Eli Lilly $LLY) might see increased utilization. However, these effects are too distant and uncertain to warrant inclusion in causal chains. The bill's low momentum—single sponsor, no cosponsors, dual referral—suggests it is not a near-term priority.
The legislative path requires passage through two committees, a floor vote in the House, Senate consideration, and presidential action. Given the current Congress is in its second session (2026), the window for passage is narrowing. Without significant bipartisan support or committee leadership sponsorship, the bill is unlikely to become law in this Congress.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →